Trial Profile
CEFTRIAXONE NEONATAL THERAPY: A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT OF CEFTRIAXONE ON HYPERBILIRUBINEMIA
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2017
Price :
$35
*
At a glance
- Drugs Ceftriaxone (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- Acronyms CEFSINT
- 05 Oct 2017 New trial record